Montefiore Health System
Antibacterial regimen reduces severity of radiation therapy-induced dermatitis
A bacterial decolonization-based regimen safely and effectively prevented development of severe acute radiation dermatitis among adults receiving radiation therapy, results of a randomized phase 2/phase 3 trial showed.
Similar prescribing patterns in RA seen between fellows, faculty in hospital system
PHILADELPHIA — Prescribing patterns of fellows seeing patients with rheumatoid arthritis in an urban, academic hospital system aligned with the teaching practices of faculty, according to findings presented at ACR Convergence 2022.
Levels of post-chemotherapy biomarker for distant metastatic recurrence vary by race
SAN ANTONIO — Levels of a prognostic biomarker for distant metastatic recurrence varied by race among a subset of women who received neoadjuvant chemotherapy, according to study results presented at San Antonio Breast Cancer Symposium.
Unexplained persistent eosinophilia may be triggered by parasitic infection
LOUISVILLE, Ky. — Parasitic infections commonly were the cause of unexplained persistent eosinophilia among inner-city patients, according to study results presented at the American College of Allergy, Asthma & Immunology Annual Meeting.
Cognitive dysfunction more common ‘than we want to admit’ in rheumatic disease
SAN DIEGO — Limited assessment tools make it difficult to determine the prevalence and severity of cognitive disorders in patients with rheumatic and autoimmune diseases, according to a speaker at the Congress of Clinical Rheumatology West.
CAR-T for non-Hodgkin lymphoma effective regardless of race or ethnicity
Black and Hispanic patients who received chimeric antigen receptor T-cell therapy for relapsed or refractory non-Hodgkin lymphoma achieved similar efficacy outcomes as white and Asian individuals, according to study results.
LXB improves functional outcomes in patients with idiopathic hypersomnia
LXB improved all measures of function and work productivity among patients with idiopathic hypersomnia, according to findings presented at the American Neurological Association Annual Meeting.
Gefapixant shows long-term efficacy for treatment of chronic cough
A pooled analysis of the COUGH-1 and COUGH-2 trials demonstrated long-term efficacy of twice-daily gefapixant out to 52 weeks in patients with refractory or unexplained chronic cough, according to data presented at the CHEST Annual Meeting.
Extra support may alleviate widespread disparities in diabetes technology adoption
Diabetes technology uptake continues to be low among people with type 1 diabetes from underrepresented groups, and providers should not overlook patients who may struggle with diabetes management, according to a speaker.
Physical therapy after COVID-19 led to lower incidence of mortality
Compared with those who did not have physical therapy, patients with COVID-19 who did had lower odds of mortality, despite being older and having more comorbidities and lower mobility on admission, according to results.